ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation

Transfusion and Apheresis Science

Volumn 35, Issue 1, 2006, Pages 59-69

  Stussi, Georg ^a,b   Halter, Jörg ^a   Schanz, Urs ^b   Seebach, Jörg D ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ERYTHROPOIETIN; IMMUNOGLOBULIN; METHOTREXATE; RITUXIMAB; THYMOCYTE ANTIBODY;

APLASIA; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; DRUG SAFETY; ERYTHROCYTE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HISTOCOMPATIBILITY GENE; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; OVERALL SURVIVAL; PLASMAPHERESIS; TRANSPLANTATION TOLERANCE; XENOTRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; ANTIBODY FORMATION; BLOOD GROUP INCOMPATIBILITY; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HUMANS; IMMUNE TOLERANCE; MODELS, IMMUNOLOGICAL; ORGAN TRANSPLANTATION; RISK FACTORS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33747612012     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2006.05.009     Document Type: Article

References (106)

1. Reddy P., and Ferrara J.L. Immunobiology of acute graft-versus-host disease. Blood Rev 17 (2003) 187-194
2. Shlomchik W.D. Antigen presentation in graft-vs-host disease. Exp Hematol 31 (2003) 1187-1197
3. Stussi G., Huggel K., Lutz H.U., et al. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Br J Haematol 130 (2005) 954-963
4. Klumpp T.R. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 8 (1991) 159-170
5. Seebach J.D., Stussi G., Passweg J.R., et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant 11 (2005) 1006-1013
6. LaRoche V., Eastlund D.T., and McCullough J. Immunohematologic aspects of allogeneic hematopoietic progenitor cell transplantation. Immunohematol 20 (2004) 217-225
7. Rowley S.D., Liang P.S., and Ulz L. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Bone Marrow Transplant 26 (2000) 749-757
8. Worel N., Greinix H.T., Keil F., et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion 42 (2002) 1293-1301
9. Hows J., Beddow K., Gordon S.E., et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 67 (1986) 177-181
10. Gajewski J.L., Petz L.D., Calhoun L., et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 79 (1992) 3076-3085
11. Kim J.G., Sohn S.K., Kim D.H., et al. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 35 (2005) 489-495
12. Petz L.D. Immune hemolysis associated with transplantation. Semin Hematol 42 (2005) 145-155
13. Robertson V.M., Dickson L.G., Romond E.H., and Ash R.C. Positive antiglobulin tests due to intravenous immunoglobulin in patients who received bone marrow transplant. Transfusion 27 (1987) 28-31
14. Lasky L.C., Warkentin P.I., Kersey J.H., et al. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Transfusion 23 (1983) 277-285
15. Bensinger W.I., Buckner C.D., Thomas E.D., and Clift R.A. ABO-incompatible marrow transplants. Transplantation 33 (1982) 427-429
16. Buckner C.D., Clift R.A., Sanders J.E., et al. ABO-incompatible marrow transplants. Transplantation 26 (1978) 233-238
17. Bensinger W.I., Baker D.A., Buckner C.D., Clift R.A., and Thomas E.D. Immunoadsorption for removal of A and B blood-group antibodies. N Engl J Med 304 (1981) 160-162
18. Bensinger W.I., Buckner C.D., Clift R.A., et al. Comparison of techniques for dealing with major ABO-incompatible marrow transplants. Transplant Proc 19 (1987) 4605-4608
19. Ho W.G., Champlin R.E., Feig S.A., and Gale R.P. Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow. Br J Haematol 57 (1984) 155-162
20. Nussbaumer W., Schwaighofer H., Gratwohl A., et al. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility. Transfusion 35 (1995) 592-595
21. Scholl S., Klink A., Mugge L.O., et al. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch. Transfusion 45 (2005) 1676-1683
22. Damodar S., George B., Mammen J., et al. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants. Bone Marrow Transplant 36 (2005) 233-235
23. Webb I.J., Soiffer R.J., Andersen J.W., et al. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation. Biol Blood Marrow Transplant 3 (1997) 267-272
24. Blacklock H.A., Gilmore M.J., Prentice H.G., et al. ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion. Lancet 2 (1982) 1061-1064
25. Braine H.G., Sensenbrenner L.L., Wright S.K., et al. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 60 (1982) 420-425
26. Dinsmore R.E., Reich L.M., Kapoor N., et al. ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentation. Br J Haematol 54 (1983) 441-449
27. Tsang K.S., Li C.K., Wong A.P., et al. Processing of major ABO-incompatible bone marrow for transplantation by using dextran sedimentation. Transfusion 39 (1999) 1212-1219
28. Raimondi R., Soli M., Lamparelli T., et al. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. Bone Marrow Transplant 34 (2004) 321-329
29. Toren A., Dacosta Y., Manny N., et al. Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation. Blood 87 (1996) 843-844
30. Laurencet F.M., Samii K., Bressoud A., et al. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility. Hematol Cell Ther 39 (1997) 159-162
31. Oziel T.S., Faucher B.C., Chabannon C., et al. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplant 19 (1997) 1155-1156
32. Salmon J.P., Michaux S., Hermanne J.P., et al. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion 39 (1999) 824-827
33. Bornhauser M., Ordemann R., Paaz U., et al. Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysis. Bone Marrow Transplant 19 (1997) 295-297
34. Bolan C.D., Childs R.W., Procter J.L., Barrett A.J., and Leitman S.F. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol 112 (2001) 787-795
35. Lapierre V., Oubouzar N., Auperin A., et al. Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation. Blood 97 (2001) 2580-2586
36. Sniecinski I.J., Oien L., Petz L.D., and Blume K.G. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 45 (1988) 530-534
37. Stussi G., Muntwyler J., Passweg J.R., et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 30 (2002) 87-93
38. Worel N., Greinix H.T., Schneider B., et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 40 (2000) 543-550
39. Lee J.H., Lee K.H., Kim S., et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant 25 (2000) 179-184
40. Benjamin R.J., Connors J.M., McGurk S., Churchill W.H., and Antin J.H. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 4 (1998) 151-156
41. Gmür J.P., Burger J., Schaffner A., et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 75 (1990) 290-295
42. Griffith L.M., McCoy Jr. J.P., Bolan C.D., et al. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 128 (2005) 668-675
43. Rozman P., Kosir A., and Bohinjec M. Is the ABO incompatibility a risk factor in bone marrow transplantation?. Transpl Immunol 14 (2005) 159-169
44. Mueller R.J., Stussi G., Odermatt B., et al. Major ABO incompatible hematopoietic stem cell transplantation: study of posttransplant pure red cell aplasia and endothelial chimerism. Xenotransplantation 13 (2006) 126-132
45. Reviron J., Schenmetzler C., Bussel A., Devergie A., and Gluckman E. Evidence for different kinds of major ABO incompatibility in transplantation due to the interplay of qualitative and quantitative factors: application to the management of 62 bone marrow recipients. Transplant Proc 19 (1987) 4623-4628
46. Wada H., Suda T., Miura Y., et al. Expression of major blood group antigens on human erythroid cells in a two phase liquid culture system. Blood 75 (1990) 505-511
47. Tulliez M., Villeval J.L., Lejeune F., et al. Expression of blood group A antigen during erythroid differentiation in A1 and A2 subjects. Leukemia 1 (1987) 44-51
48. Stussi G., Huggel K., Schanz U., Passweg J.R., and Seebach J.D. Levels of anti-A/B antibodies after ABO-incompatible hematopoietic stem cell transplantation. Transplant Proc 37 (2005) 1385-1387
49. Veelken H., Wasch R., Behringer D., Bertz H., and Finke J. Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning. Bone Marrow Transplant 26 (2000) 911-915
50. Barge A.J., Johnson G., Witherspoon R., and Torok-Storb B. Antibody-mediated marrow failure after allogeneic bone marrow transplantation. Blood 74 (1989) 1477-1480
51. Selleri C., Raiola A., De R.G., et al. CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation. Bone Marrow Transplant 22 (1998) 605-607
52. Bierman P.J., Warkentin P., Hutchins M.R., and Klassen L.W. Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin. Leuk Lymphoma 9 (1993) 169-171
53. Martelli M., Ponchio L., Beguin Y., et al. Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin. Haematologica 79 (1994) 456-459
54. Maschan A.A., Skorobogatova E.V., Balashov D.N., et al. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant 30 (2002) 405-407
55. Ohta S., Yokoyama H., Ise T., et al. Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation. Intern Med 36 (1997) 487-491
56. Roychowdhury D.F., and Linker C.A. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. Bone Marrow Transplant 16 (1995) 471-472
57. Ustun C., Celebi H., Arat M., et al. Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case report. Ther Apher 3 (1999) 275-277
58. Verholen F., Stalder M., Helg C., and Chalandon Y. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. Eur J Haematol 73 (2004) 441-446
59. Warkentin P.I., Hilden J.M., Kersey J.H., Ramsay N.K., and McCullough J. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang 48 (1985) 89-104
60. Mielcarek M., Leisenring W., Torok-Storb B., and Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 96 (2000) 1150-1156
61. Gale R.P., Feig S., Ho W., et al. ABO blood group system and bone marrow transplantation. Blood 50 (1977) 185-194
62. Canals C., Muniz-Diaz E., Martinez C., et al. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion 44 (2004) 1603-1611
63. Mehta J., Powles R., Sirohi B., et al. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?. Bone Marrow Transplant 29 (2002) 853-859
64. Goldman J., Liesveld J., Nichols D., Heal J., and Blumberg N. ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leuk Res 27 (2003) 489-491
65. Worel N., Kalhs P., Keil F., et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion 43 (2003) 1153-1161
66. Benjamin R.J., McGurk S., Ralston M.S., Churchill W.H., and Antin J.H. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 39 (1999) 179-187
67. Erker C.G., Steins M.B., Fischer R.J., et al. The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion 45 (2005) 1382-1390
68. Benjamin R.J., and Antin J.H. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion 39 (1999) 1273-1274
69. Heal J.M., and Blumberg N. The second century of ABO: and now for something completely different. Transfusion 39 (1999) 1155-1159
70. Martinez M.T., Bucher C., Stussi G., et al. Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant 36 (2005) 993-1000
71. Bacigalupo A., Van Lint M.T., Occhini D., et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 45 (1988) 1091-1094
72. Keever-Taylor C.A., Bredeson C., Loberiza F.R., et al. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant 7 (2001) 620-630
73. Hershko C., Gale R.P., Ho W., and Fitchen J. ABH antigens and bone marrow transplantation. Br J Haematol 44 (1980) 65-73
74. Kalaycioglu M., Copelan E., Avalos B., et al. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. Bone Marrow Transplant 15 (1995) 105-110
75. Tanabe K., Takahashi K., Sonda K., et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 65 (1998) 224-228
76. Karakayali H., Moray G., Demirag A., et al. Long-term follow-up of ABO-incompatible renal transplant recipients. Transplant Proc 31 (1999) 256-257
77. Takahashi K., Saito K., Takahara S., et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4 (2004) 1089-1096
78. Takahashi K. ABO incompatible kidney transplantation (2002), Elsevier Science Ltd
79. Ishida H., Koyama I., Sawada T., et al. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation. Transplantation 70 (2000) 681-685
80. Shishido S., Asanuma H., Tajima E., et al. Abo-incompatible living-donor kidney transplantation in children. Transplantation 72 (2001) 1037-1042
81. Tyden G., Kumlien G., Genberg H., et al. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 5 (2005) 145-148
82. Winters J.L., Gloor J.M., Pineda A.A., Stegall M.D., and Moore S.B. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apheresis 19 (2004) 79-85
83. Gloor J.M., Lager D.J., Moore S.B., et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 75 (2003) 971-977
84. Bailey L.L., Nehlsen-Cannarella S.L., Concepcion W., and Jolley W.B. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 254 (1985) 3321-3329
85. West L.J., Pollock-Barziv S.M., Dipchand A.I., et al. ABO-incompatible heart transplantation in infants. N Engl J Med 344 (2001) 793-800
86. Fan X., Ang A., Pollock-Barziv S.M., et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 10 (2004) 1227-1233
87. Rao J.N., Hasan A., Hamilton J.R., et al. ABO-incompatible heart transplantation in infants: the Freeman Hospital experience. Transplantation 77 (2004) 1389-1394
88. Schmoeckel M., Dabritz S.H., Kozlik-Feldmann R., et al. Successful ABO-incompatible heart transplantation in two infants. Transpl Int 18 (2005) 1210-1214
89. Rodriguez R.J., Addonizio L.J., Lamour J.M., et al. Pediatric heart transplantation across ABO blood type barriers: a case study. Prog Transplant 15 (2005) 161-165
90. Pierson III R.N., Loyd J.E., Goodwin A., et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy1. Transplantation 74 (2002) 79-84
91. Koestner S.C., Kappeler A., Schaffner T., et al. Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation. Lancet 363 (2004) 1523-1525
92. Banner N.R., Rose M.L., Cummins D., et al. Management of an ABO-incompatible lung transplant. Am J Transplant 4 (2004) 1192-1196
93. Cooper D.K. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J Heart Transplant 9 (1990) 376-381
94. Campion E.W. A death at Duke. N Engl J Med 348 (2003) 1083-1084
95. Pancevski B. Swiss hospital investigates heart transplant "experiment". Lancet 366 (2005) 624
96. Soares M.P., Lin Y., Sato K., Stuhlmeier K.M., and Bach F.H. Accommodation. Immunol Today 20 (1999) 434-437
97. Fehr T., and Sykes M. Tolerance induction in clinical transplantation. Transpl Immunol 13 (2004) 117-130
98. West L.J. B-cell tolerance following ABO-incompatible infant heart transplantation. Transplantation 81 (2006) 301-307
99. Mohiuddin M.M., Ogawa H., Yin D.P., Shen J., and Galili U. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen. Transplantation 75 (2003) 258-262
100. Ogawa H., Mohiuddin M.M., Yin D.P., et al. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation 77 (2004) 366-373
101. Quaini F., Urbanek K., Beltrami A.P., et al. Chimerism of the transplanted heart. N Engl J Med 346 (2002) 5-15
102. Lagaaij E.L., Cramer-Knijnenburg G.F., van Kemenade F.J., et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 357 (2001) 33-37
103. Mezey E., Key S., Vogelsang G., et al. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci USA 100 (2003) 1364-1369
104. Korbling M., Katz R.L., Khanna A., et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 346 (2002) 738-746
105. Thiele J., Varus E., Wickenhauser C., et al. Chimerism of cardiomyocytes and endothelial cells after allogeneic bone marrow transplantation in chronic myeloid leukemia. An autopsy study. Pathologe 23 (2002) 405-410
106. Meignin V., Soulier J., Brau F., et al. Little evidence of donor-derived epithelial cells in early digestive acute graft-versus-host disease. Blood 103 (2004) 360-362